GCM
ECTE

Goldman Capital Management’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Goldman Capital Management’s Portfolio ECTE Stock Details ECTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-100,000
Closed -$249K – 30
2013
Q2 		$249K Buy
+100,000
New +$524K 0.14% 32

Other funds holding ECTE

PM
Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EEG
E.E. Geduld $178M AUM 29.34% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NPC
National Planning Corporation El Segundo, California $726K AUM 14.28% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Capital Management's ECTE Position: Q3 2013 in Review

Goldman Capital Management sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q3 2013, closing a stake of 100,000 shares — an estimated $249K sold.

Goldman Capital Management first reported a position in ECTE in Q2 2013 and held it in 1 quarter. The position peaked at $249K in Q2 2013. 23 funds tracked by Wall St. Rank hold ECTE as of Q3 2013.

  • Goldman Capital Management reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q3 2013 after selling out during the quarter.
  • Goldman Capital Management sold 100,000 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q3 2013, an estimated $249K.
  • Goldman Capital Management first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q2 2013 and held it in 1 quarter.
  • Goldman Capital Management's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $249K in Q2 2013.
  • 23 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q3 2013.

Based on Goldman Capital Management's 13F filing for Q3 2013, filed 15 Nov 2013.